150 related articles for article (PubMed ID: 8136263)
21. Bcl-2 antisense oligonucleotides enhance the cytotoxicity of chlorambucil in B-cell chronic lymphocytic leukaemia cells.
Pepper C; Hooper K; Thomas A; Hoy T; Bentley P
Leuk Lymphoma; 2001 Jul; 42(3):491-8. PubMed ID: 11699414
[TBL] [Abstract][Full Text] [Related]
22. Effect of interleukins on the proliferation and survival of B cell chronic lymphocytic leukaemia cells.
Mainou-Fowler T; Copplestone JA; Prentice AG
J Clin Pathol; 1995 May; 48(5):482-7. PubMed ID: 7629299
[TBL] [Abstract][Full Text] [Related]
23. Protection from apoptotic cell death by interleukin-4 is increased in previously treated chronic lymphocytic leukemia patients.
Frankfurt OS; Byrnes JJ; Villa L
Leuk Res; 1997 Jan; 21(1):9-16. PubMed ID: 9029180
[TBL] [Abstract][Full Text] [Related]
24. Fibronectin interaction with alpha4beta1 integrin prevents apoptosis in B cell chronic lymphocytic leukemia: correlation with Bcl-2 and Bax.
de la Fuente MT; Casanova B; Garcia-Gila M; Silva A; Garcia-Pardo A
Leukemia; 1999 Feb; 13(2):266-74. PubMed ID: 10025901
[TBL] [Abstract][Full Text] [Related]
25. CD5-induced apoptosis of B cells in some patients with chronic lymphocytic leukemia.
Pers JO; Berthou C; Porakishvili N; Burdjanadze M; Le Calvez G; Abgrall JF; Lydyard PM; Youinou P; Jamin C
Leukemia; 2002 Jan; 16(1):44-52. PubMed ID: 11840262
[TBL] [Abstract][Full Text] [Related]
26. Basic fibroblast growth factor (bFGF) upregulates the expression of bcl-2 in B cell chronic lymphocytic leukemia cell lines resulting in delaying apoptosis.
König A; Menzel T; Lynen S; Wrazel L; Rosén A; Al-Katib A; Raveche E; Gabrilove JL
Leukemia; 1997 Feb; 11(2):258-65. PubMed ID: 9009090
[TBL] [Abstract][Full Text] [Related]
27. Interferon-alpha-mediated prevention of in vitro apoptosis of chronic lymphocytic leukemia B cells: role of bcl-2 and c-myc.
Chaouchi N; Wallon C; Taieb J; Auffredou MT; Tertian G; Lemoine FM; Delfraissy JF; Vazquez A
Clin Immunol Immunopathol; 1994 Nov; 73(2):197-204. PubMed ID: 7923926
[TBL] [Abstract][Full Text] [Related]
28. Farnesyltransferase inhibitor BMS-214662 induces apoptosis in B-cell chronic lymphocytic leukemia cells.
Marzo I; Pérez-Galán P; Giraldo P; López-Royuela N; Gómez-Benito M; Larrad L; Lasierra P; Rubio-Félix D; Anel A; Naval J
Leukemia; 2004 Oct; 18(10):1599-604. PubMed ID: 15356656
[TBL] [Abstract][Full Text] [Related]
29. Drug-induced apoptosis in B-cell chronic lymphocytic leukemia: relationship between p53 gene mutation and bcl-2/bax proteins in drug resistance.
Thomas A; El Rouby S; Reed JC; Krajewski S; Silber R; Potmesil M; Newcomb EW
Oncogene; 1996 Mar; 12(5):1055-62. PubMed ID: 8649796
[TBL] [Abstract][Full Text] [Related]
30. Doxorubicin and a butyric acid derivative effectively reduce levels of BCL-2 protein in the cells of chronic lymphocytic leukemia patient.
Rabizadeh E; Bairey O; Aviram A; Ben-Dror I; Shaklai M; Zimra Y
Eur J Haematol; 2001 Apr; 66(4):263-71. PubMed ID: 11380606
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-4 (IL-4) inhibits proliferation and spontaneous cytokine release by chronic lymphocytic leukaemia cells.
Reittie JE; Hoffbrand AV
Leuk Res; 1994 Jan; 18(1):55-60. PubMed ID: 8289467
[TBL] [Abstract][Full Text] [Related]
32. Significance of phosphotyrosine proteins, Bcl-2 and p53 for apoptosis in resting B-chronic lymphocytic leukemia (CLL) cells.
Laytragoon-Lewin N; Rossmann ED; Castro J; Mellstedt H
Int J Cancer; 2002 Jan; 97(3):344-8. PubMed ID: 11774286
[TBL] [Abstract][Full Text] [Related]
33. A combination of cytokines rescues highly purified leukemic CLL B-cells from spontaneous apoptosis in vitro.
Ghamlouch H; Ouled-Haddou H; Damaj G; Royer B; Gubler B; Marolleau JP
PLoS One; 2013; 8(3):e60370. PubMed ID: 23555960
[TBL] [Abstract][Full Text] [Related]
34. Role of myeloid cell factor-1 (Mcl-1) in chronic lymphocytic leukemia.
Johnston JB; Paul JT; Neufeld NJ; Haney N; Kropp DM; Hu X; Cheang M; Gibson SB
Leuk Lymphoma; 2004 Oct; 45(10):2017-27. PubMed ID: 15370246
[TBL] [Abstract][Full Text] [Related]
35. Pharmacological inhibitors of NF-kappaB accelerate apoptosis in chronic lymphocytic leukaemia cells.
Pickering BM; de Mel S; Lee M; Howell M; Habens F; Dallman CL; Neville LA; Potter KN; Mann J; Mann DA; Johnson PW; Stevenson FK; Packham G
Oncogene; 2007 Feb; 26(8):1166-77. PubMed ID: 16924235
[TBL] [Abstract][Full Text] [Related]
36. Chlorambucil resistance in B-cell chronic lymphocytic leukaemia is mediated through failed Bax induction and selection of high Bcl-2-expressing subclones.
Pepper C; Thomas A; Hoy T; Bentley P
Br J Haematol; 1999 Mar; 104(3):581-8. PubMed ID: 10086798
[TBL] [Abstract][Full Text] [Related]
37. Engagement of CD31 delivers an activating signal that contributes to the survival of chronic lymphocytic leukaemia cells.
Poggi A; Prevosto C; Catellani S; Rocco I; Garuti A; Zocchi MR
Br J Haematol; 2010 Nov; 151(3):252-64. PubMed ID: 20813004
[TBL] [Abstract][Full Text] [Related]
38. Modulation of IL-4 level by fludarabine and its relation to apoptosis in chronic B-cell lymphocytic leukemia.
Shamaa LA; Hussein Ael-S; Balbaa OA; Farahat NM; Ali MA
Egypt J Immunol; 2008; 15(1):181-92. PubMed ID: 20306682
[TBL] [Abstract][Full Text] [Related]
39. Bcl-2 expression in chronic lymphocytic leukemia and its correlation with the induction of apoptosis and clinical outcome.
Robertson LE; Plunkett W; McConnell K; Keating MJ; McDonnell TJ
Leukemia; 1996 Mar; 10(3):456-9. PubMed ID: 8642861
[TBL] [Abstract][Full Text] [Related]
40. Role of the CD40 and CD95 (APO-1/Fas) antigens in the apoptosis of human B-cell malignancies.
Wang D; Freeman GJ; Levine H; Ritz J; Robertson MJ
Br J Haematol; 1997 May; 97(2):409-17. PubMed ID: 9163608
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
